# Fulgent Genetics, Inc.: Form 8-K, filed May 14, 2026

- Company: [Fulgent Genetics, Inc.](/companies/flgt.md) (CIK 1674930)
- Form: 8-K
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 16:27 ET
- Period: 2026-05-14
- Accession: 0001193125-26-224147
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674930/000119312526224147/flgt-20260514.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674930/000119312526224147/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674930/000119312526224147/flgt-20260514.htm

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-224147. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.